Neumora Therapeutics Inc.... (NMRA)
NASDAQ: NMRA
· Real-Time Price · USD
1.62
0.04 (2.53%)
At close: Aug 15, 2025, 3:59 PM
1.66
2.47%
After-hours: Aug 15, 2025, 07:51 PM EDT
Neumora Therapeutics Common Stock Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Cash & Equivalents | 124.52M | 126.86M | 142.15M | 275.71M | 150.68M | 182.93M | 374.04M | 412.28M | 204.22M | 210.87M | 240.94M | 174.4M | 291.18M | 409.25M | 439.14M |
Short-Term Investments | 93.06M | 122.49M | 165.43M | 65.59M | 220.96M | 239.79M | 79.94M | 97.28M | 119.98M | 134.68M | 130.94M | 153.11M | 58.44M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 1.21M | 302K | 9.85M | 9.91M | 9.89M | 19.5M | 23.51M | 9.37M | 13.81M | n/a | n/a |
Other Long-Term Assets | 298K | n/a | n/a | n/a | n/a | 1.21M | 1.21M | 1.21M | 4.77M | 2.93M | 4.13M | 4.13M | 2.3M | 9.65M | 4.39M |
Receivables | n/a | n/a | n/a | n/a | 1.63M | 906K | 939K | 668K | 594K | 787K | 919K | 585K | 269K | 200K | 270K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -668K | n/a | n/a | 50K | n/a | 50K | n/a | n/a |
Other Current Assets | 5.32M | 5.51M | 6.48M | 7.3M | n/a | n/a | n/a | n/a | n/a | 13.63M | 50K | 50K | 50K | 125K | 125K |
Total Current Assets | 222.91M | 254.87M | 314.06M | 348.61M | 398.32M | 442.79M | 478.28M | 525.74M | 336.61M | 359.96M | 387.95M | 340.39M | 362.92M | 415.6M | 443.08M |
Property-Plant & Equipment | 618K | 1.88M | 2.92M | 3.93M | 4.94M | 5.91M | 6.86M | 7.89M | 8.68M | 9.71M | 10.64M | 9.7M | 3.8M | 4.04M | 4.5M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 916K | 1.88M | 2.92M | 3.93M | 6.15M | 7.43M | 17.92M | 19.01M | 23.34M | 32.13M | 38.28M | 23.19M | 19.91M | 13.69M | 8.89M |
Total Assets | 223.82M | 256.75M | 316.97M | 352.54M | 404.47M | 450.21M | 496.19M | 544.75M | 359.95M | 392.09M | 426.23M | 363.58M | 382.84M | 429.3M | 451.98M |
Account Payables | 644K | 1.05M | 3.31M | 6.11M | 1.08M | 1.49M | 337K | 2.23M | 8.17M | 1.14M | 7.15M | 3.02M | 1.65M | 1.64M | 2.51M |
Deferred Revenue | n/a | n/a | n/a | n/a | -14.45M | 19.49M | 21.26M | 23.35M | 14.44M | n/a | 11.54M | 15.29M | 14.41M | 19.1M | 15.96M |
Short-Term Debt | 171K | n/a | n/a | n/a | 3.61M | 3.49M | 3.38M | n/a | n/a | 3.35M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 20.34M | 6.28M | 10.11M | 22.89M | 3.98M | 1.3M | 6.77M | 9.73M | 6.95M | 17.3M | 10.04M | 7.02M | 4.26M | 8.13M | 6.06M |
Total Current Liabilities | 21.16M | 28.38M | 29.89M | 31.74M | 23.13M | 24.61M | 25.11M | 29.12M | 26.09M | 21.78M | 23.7M | 22.86M | 17.93M | 23.28M | 20.95M |
Long-Term Debt | 339K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 19.45M | n/a | 22K | 55K | 89K | 122K | 155K | 188K | 843.91M | 4.55M | 844.32M | 730.64M | 730.2M | 730.24M | 730.15M |
Total Long-Term Liabilities | 19.79M | n/a | 22K | 55K | 89K | 1.06M | 2.01M | 2.93M | 847.4M | 4.55M | 849.39M | 735.43M | 730.93M | 731.24M | 731.47M |
Total Liabilities | 40.95M | 28.38M | 29.91M | 31.8M | 23.21M | 25.67M | 27.12M | 32.06M | 873.49M | 26.33M | 873.08M | 758.29M | 748.85M | 754.52M | 752.42M |
Total Debt | 510K | 938K | 1.85M | 2.75M | 3.61M | 4.43M | 5.23M | 6.14M | 6.82M | 7.64M | 8.44M | 7.38M | 1.76M | 2.05M | 2.55M |
Common Stock | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 15K | 16K | 16K | 3K | 15K | 15K | 14K | 13K |
Retained Earnings | -1.07B | -1.02B | -947.22M | -888.4M | -815.86M | -757.15M | -703.43M | -594.7M | -541.68M | -503.13M | -467.51M | -410.02M | -379.65M | -336.61M | -309.64M |
Comprehensive Income | -15K | -3K | 62K | 105K | -187K | -148K | -76K | -311K | -448K | -298K | -774K | -870K | -178K | n/a | n/a |
Shareholders Equity | 182.88M | 228.36M | 287.06M | 320.74M | 381.26M | 424.54M | 469.08M | 512.69M | -513.54M | 365.77M | -446.85M | -394.71M | -366.02M | -325.22M | -300.45M |
Total Investments | n/a | 122.49M | 165.43M | 65.59M | 222.17M | 240.09M | 89.79M | 107.19M | 129.87M | 154.18M | 154.45M | 162.48M | 72.25M | n/a | n/a |